Shares of LifePoint Health Inc (NASDAQ:LPNT) have been assigned an average rating of “Hold” from the eighteen research firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and one has given a buy rating to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $58.45.
Several equities research analysts recently issued reports on LPNT shares. William Blair reissued a “hold” rating on shares of LifePoint Health in a research note on Friday, August 17th. BidaskClub raised LifePoint Health from a “sell” rating to a “hold” rating in a research note on Wednesday, September 26th. Finally, Zacks Investment Research raised LifePoint Health from a “hold” rating to a “strong-buy” rating and set a $74.00 price objective for the company in a research note on Wednesday, October 10th.
Hedge funds have recently modified their holdings of the business. Seven Eight Capital LP bought a new stake in LifePoint Health during the third quarter worth about $2,776,000. Acadian Asset Management LLC bought a new stake in LifePoint Health during the second quarter worth about $263,000. MetLife Investment Advisors LLC lifted its stake in shares of LifePoint Health by 67.9% in the 2nd quarter. MetLife Investment Advisors LLC now owns 40,838 shares of the company’s stock valued at $1,993,000 after acquiring an additional 16,514 shares during the last quarter. Spark Investment Management LLC bought a new stake in shares of LifePoint Health in the 2nd quarter valued at about $1,015,000. Finally, Cubist Systematic Strategies LLC lifted its stake in shares of LifePoint Health by 116.6% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 33,099 shares of the company’s stock valued at $1,615,000 after acquiring an additional 17,817 shares during the last quarter. 94.63% of the stock is owned by hedge funds and other institutional investors.
NASDAQ:LPNT remained flat at $$64.99 during trading hours on Thursday. The company has a market capitalization of $2.52 billion, a price-to-earnings ratio of 17.90, a P/E/G ratio of 1.73 and a beta of 0.51. LifePoint Health has a 1-year low of $41.45 and a 1-year high of $65.35. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.85 and a quick ratio of 1.63.
LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Friday, October 26th. The company reported $1.24 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.25. The company had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.55 billion. LifePoint Health had a return on equity of 7.80% and a net margin of 0.59%. The firm’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the company earned $0.80 earnings per share. Equities analysts predict that LifePoint Health will post 4.64 earnings per share for the current fiscal year.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Featured Story: Trading Penny Stocks
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.